ACHE and Alzheimer disease: The drugs approved by the US Food and Drug Administration (FDA) for the treatment of AD are mainly AChE inhibitors, including donepezil, rivastigmine and tacrine [22], but they also have significant side effects and toxicity, and low bioavailability.